Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Montrucchio G et al. Potential angiogenic role of platelet-activating factor in human breast cancer. 1998 Am. J. Pathol. pmid:9811351
O'Flaherty JT et al. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. 1981 Am. J. Pathol. pmid:6274199
Reznichenko A and Korstanje R The role of platelet-activating factor in mesangial pathophysiology. 2015 Am. J. Pathol. pmid:25655028
Rampart M and Williams TJ Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. 1986 Am. J. Pathol. pmid:3524253
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Montrucchio G et al. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. 1997 Am. J. Pathol. pmid:9250168
O'Flaherty JT et al. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. 1981 Am. J. Pathol. pmid:7223864
Boccellino M et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. 2005 Am. J. Pathol. pmid:15855650
Montrucchio G et al. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. 1990 Am. J. Pathol. pmid:2372044
Stimler NP and O'Flaherty JT Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. 1983 Am. J. Pathol. pmid:6624879
Warren JS Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. 1992 Am. J. Pathol. pmid:1519663
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
Valone FH and Goetzl EJ Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). 1983 Am. J. Pathol. pmid:6624880
Bussolati B et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. 2000 Am. J. Pathol. pmid:11073830
Bussolati B et al. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. 1999 Am. J. Pathol. pmid:10027419
Gonzalez-Crussi F and Hsueh W Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. 1983 Am. J. Pathol. pmid:6859226
Camussi G et al. Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. 1983 Am. J. Pathol. pmid:6859232
Zhou W et al. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. 1993 Am. J. Pathol. pmid:8494049
Humphrey DM Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine. 1990 Am. J. Pathol. pmid:2407127
Biancone L et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. 1999 Am. J. Pathol. pmid:10550329
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Hoffman DR et al. The role of platelet-activating factor in human fetal lung maturation. 1986 Am. J. Obstet. Gynecol. pmid:3728606
Tabor BL et al. Platelet-activating factor antagonists decrease lung protein leak in preterm ventilated rabbits. 1992 Am. J. Obstet. Gynecol. pmid:1530043
Narahara H and Johnston JM Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. 1993 Am. J. Obstet. Gynecol. pmid:8372856
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Benedetto C et al. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. 1989 Am. J. Obstet. Gynecol. pmid:2912073
Morris C et al. Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. 1992 Am. J. Obstet. Gynecol. pmid:1566774
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Zhu YP et al. The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. 1992 Am. J. Obstet. Gynecol. pmid:1314480
Rowland BL et al. Elevated circulating concentrations of platelet activating factor in preeclampsia. 2000 Am. J. Obstet. Gynecol. pmid:11035340
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
Hoffman DR et al. Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. 1990 Am. J. Obstet. Gynecol. pmid:2309839
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Roudebush WE et al. Platelet activating factor enhances in vitro fertilization of rabbit oocytes. 1990 Am. J. Obstet. Gynecol. pmid:2240122
Minhas BS et al. Effects of platelet activating factor on mouse oocyte fertilization in vitro. 1989 Am. J. Obstet. Gynecol. pmid:2603931
Frostegård J et al. Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion. 2003 Am. J. Obstet. Gynecol. pmid:14520236
Silver RK et al. Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production. 1991 Am. J. Obstet. Gynecol. pmid:1750472
Minhas BS Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. 1993 Am. J. Obstet. Gynecol. pmid:8475981
Sueoka K et al. Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. 1988 Am. J. Obstet. Gynecol. pmid:3207134
Perico N and Remuzzi G Role of platelet-activating factor in renal immune injury and proteinuria. 1990 Am. J. Nephrol. pmid:2256482
Kees-Folts D and Diamond JR Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. 1993 Am. J. Nephrol. pmid:8116689
Camussi G et al. Platelet-activating factor in renal diseases. 1989 Am. J. Nephrol. pmid:2646923
Ganong BR Roles of lipid turnover in transmembrane signal transduction. 1991 Am. J. Med. Sci. pmid:1661067
Muirhead EE et al. Biologic contrasts between medullipin I and vasoactive glyceryl compounds. 1989 Am. J. Med. Sci. pmid:2764021
Gaylord MS et al. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. 1996 Am. J. Med. Sci. pmid:8853062
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Wright NR et al. Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction. 2016 Am. J. Med. pmid:26524710
Tetta C et al. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. 1997 Am. J. Kidney Dis. pmid:9372980